Ultrafiltration in serum protein binding determinations.
about
Recent developments in protein-ligand affinity mass spectrometry.Application of hollow fiber-supported liquid-phase microextraction coupled with HPLC for the determination of guaifenesin enantiomer-protein binding.Quantitation of unbound sunitinib and its metabolite N-desethyl sunitinib (SU12662) in human plasma by equilibrium dialysis and liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study.Role of chloride and intracellular pH on the activity of the rat hepatocyte organic anion transporter.Characterization of interactions between methoxatin disodium salt and human serum albumin by pressure-assisted capillary electrophoresis/frontal analysis and circular dichroism spectroscopy.Characterization of drug interactions with serum proteins by using high-performance affinity chromatography.Incorporating High-Throughput Exposure Predictions With Dosimetry-Adjusted In Vitro Bioactivity to Inform Chemical Toxicity Testing.Protein binding of antimicrobials: methods for quantification and for investigation of its impact on bacterial killing.CHROMATOGRAPHIC ANALYSIS OF DRUG INTERACTIONS IN THE SERUM PROTEOME.Evaluation of indole-based probes for high-throughput screening of drug binding to human serum albumin: Analysis by high-performance affinity chromatography.Characterization of drug-protein interactions in blood using high-performance affinity chromatography.Protein binding: do we ever learn?Analysis of biomolecular interactions using affinity microcolumns: a review.Analytical methods for kinetic studies of biological interactions: A reviewSimple spectrophotometric assay for measuring protein binding of penem antibiotics to human serum.Hypotonic intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in mice.Characteristics of ceftriaxone binding to immunoglobulin G and potential clinical significance.Metabolic disposition and pharmacokinetics of the antiviral agent 6-methoxypurine arabinoside in rats and monkeys.Measurement of 'free' gold in patients receiving disodium aurothiomalate and the association of high free to total gold levels with toxicity.Decreased systemic clearance of lorazepam in humans with spinal cord injury.Pharmacokinetics and distribution of fluvoxamine to the brain in rats under oxidative stress.Pharmacokinetics of clomipramine, an antidepressant, in poloxamer 407-induced hyperlipidaemic model rats.Free insulin-like growth factors (IGF-I and IGF-II) in human serum.Age-dependent alteration of the serum-unbound fraction of nicardipine, a calcium-channel blocker, in man.Pharmacokinetics of ibuprofen in man--III: Plasma protein binding.Unbound fraction of ertapenem in intensive care unit patients.Unbound fraction of vancomycin in intensive care unit patients.
P2860
Q33740704-42A16928-0E8C-4B92-8348-76675B9D83A5Q34079063-511E1D14-F634-4BD4-833E-FFF7A01DCAEEQ34132880-3CD23151-7298-4371-BB65-00811F178ADEQ34186745-51C31807-D524-4DCA-BC68-2F9800334DEFQ35172118-BC203E12-7FE0-4143-B822-EA453571B3DBQ35215569-D4155A18-294D-4BDB-A0E0-FAD1F86B3ABEQ36204768-CE54CA57-5D91-4F26-9488-73174CC46A1FQ37149078-5637D789-996F-4CF0-B767-1DCFAD2508F7Q37287840-7E684663-F442-4B30-B3D4-02ED7ED50667Q37397994-E125A4D4-ED78-487E-93DF-5BD67ABFEACBQ37408194-4B3363C5-E9E7-429B-B664-85C60AA19331Q37871252-BFC9FC56-E6F1-4791-B38D-36D89CB82B89Q38191351-A3E74E08-5D75-42D3-A368-D6F4A26D1D9CQ38363066-A75C2672-4FD6-4C17-A4E3-B8D13EE8E417Q39817604-F90C6681-2570-4F12-BB8A-AA507354DA7BQ39994801-6FEB50F2-F387-4C86-9BE1-CF2F0E629307Q40087922-43170B77-4CF2-4ABA-BD76-DEBC30533046Q40284305-863A76E5-6C62-4F8F-B034-1F5EC2125644Q41199267-D15B9F56-949E-44CF-9DC2-E5A8CFAD390CQ46685696-132CBAA4-DB79-47FA-8D74-FA2291099BFCQ48578124-00379A21-86EE-420C-923F-6693008D1DF1Q50280080-E875B8EE-B9F5-43AA-8FE8-DC49BC1A3FA2Q51594543-160A19E6-7B79-4A35-94DB-F29AD15332E4Q52289474-74216672-7343-4E5D-9EF8-4648F5E54CCEQ52433068-ED81BFA6-5240-4F43-A986-DF4B10C40DE8Q52875965-3D173D46-065C-4045-BF34-842CC8DDBFA3Q52882610-76DC2035-FE12-4DBA-ABF3-0B0867442F12
P2860
Ultrafiltration in serum protein binding determinations.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年学术文章
@wuu
1981年学术文章
@zh
1981年学术文章
@zh-cn
1981年学术文章
@zh-hans
1981年学术文章
@zh-my
1981年学术文章
@zh-sg
1981年學術文章
@yue
1981年學術文章
@zh-hant
name
Ultrafiltration in serum protein binding determinations.
@en
Ultrafiltration in serum protein binding determinations.
@nl
type
label
Ultrafiltration in serum protein binding determinations.
@en
Ultrafiltration in serum protein binding determinations.
@nl
prefLabel
Ultrafiltration in serum protein binding determinations.
@en
Ultrafiltration in serum protein binding determinations.
@nl
P356
P1476
Ultrafiltration in serum protein binding determinations.
@en
P2093
P304
P356
10.1002/JPS.2600700208
P407
P577
1981-02-01T00:00:00Z